The Trump administration advanced a plan to promote peptide drugs, a policy favored by RFK Jr. This represents a shift in pharmaceutical regulation aligned with RFK Jr.'s health policy preferences.
Score History
v1 Oct 18: Dmg=— Hype=— (system:weekly_freeze) — Weekly freeze: 2026-10-11